# AVANIR PHARMACEUTICALS, INC.

AVANIR PHARMACEUTICALS, INC. is a company headquartered in Aliso Viejo, CA, United States.

## Company overview

- **Legal name:** AVANIR PHARMACEUTICALS, INC.
- **Former names in filing history:** AVANIR PHARMACEUTICALS (1998-12-07 to 2009-04-02); LIDAK PHARMACEUTICALS (1995-11-21 to 1998-08-14)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Aliso Viejo, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** September 30
- **SEC CIK:** 0000858803

## About

AVANIR PHARMACEUTICALS, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000858803, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2014-12-10, it reported annual revenue of USD 115,029,000; net income of USD -50,436,000; total assets of USD 306,983,000 for the fiscal period ended 2014-09-30. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2014 (period ended 2014-09-30)

- **Revenue:** $115.0M (USD 115,029,000)
- **Net income:** -$50.4M (USD -50,436,000)
- **Total assets:** $307.0M (USD 306,983,000)
- **Cash and equivalents:** $271.9M (USD 271,870,000)

### FY2013 (period ended 2013-09-30)

- **Revenue:** $75.4M (USD 75,365,884)
- **Net income:** -$75.5M (USD -75,475,863)
- **Total assets:** $76.1M (USD 76,079,007)
- **Cash and equivalents:** $55.3M (USD 55,259,073)
- **Operating cash flow:** -$65.4M (USD -65,422,227)
- **Later filings:** Revenue, Net income, Total assets, Cash and equivalents: shown as originally filed; later filings report different values for the same periods.

### FY2012 (period ended 2012-09-30)

- **Net income:** -$59.7M (USD -59,743,827)
- **Total assets:** $86.0M (USD 86,011,796)
- **Cash and equivalents:** $69.8M (USD 69,778,406)
- **Operating cash flow:** -$57.7M (USD -57,656,620)
- **Later filings:** Net income, Cash and equivalents: shown as originally filed; later filings report different values for the same periods.

### FY2011 (period ended 2011-09-30)

- **Net income:** -$60.6M (USD -60,631,563)
- **Total assets:** $89.6M (USD 89,648,994)
- **Cash and equivalents:** $79.5M (USD 79,542,564)
- **Operating cash flow:** -$56.5M (USD -56,521,289)
- **Later filings:** Cash and equivalents: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2015-01-13 — period 2015-01-13 — 8-K
- Form 10-K — filed 2014-12-10 — period 2014-09-30 — 10-K
- Form 8-K — filed 2014-12-02 — period 2014-12-01 — FORM 8-K
- Form 8-K — filed 2014-11-28 — period 2014-11-26 — 8-K
- Form 8-K — filed 2014-11-12 — period 2014-11-10 — FORM 8-K
- Form 8-K — filed 2014-11-07 — period 2014-11-07 — FORM 8-K
- Form 8-K — filed 2014-09-25 — period 2014-09-23 — FORM 8-K
- Form 8-K — filed 2014-09-15 — period 2014-09-15 — FORM 8-K
- Form 10-Q — filed 2014-08-07 — period 2014-06-30 — FORM 10-Q
- Form 8-K — filed 2014-08-05 — period 2014-08-05 — FORM 8-K
- Form SC 13G — filed 2014-06-10 — SC 13G
- Form 8-K — filed 2014-05-07 — period 2014-05-07 — FORM 8-K

---

Updated: 2026-10-23T20:08:00Z

Canonical page: https://altss.com/profile/avanir-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology